Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT00289549 · COMPLETED

Trial details

NCT number: NCT00289549
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic

Start date: 2005-06-01
Primary completion: 2009-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.